A client with a cold is taking the antitussive medication benzonatate. Which assessment information indicates to the nurse that the medication is effective?
Expectorating bronchial secretions.
Reports reduced nasal discharge.
Able to sleep through the night.
Denies having coughing spells.
The Correct Answer is D
Choice A reason: Expectorating bronchial secretions is not an assessment information that indicates that the antitussive medication benzonatate is effective. Benzonatate is a medication that suppresses the cough reflex by numbing the throat and lungs. It does not loosen or thin the mucus in the airways, which would facilitate expectoration.
Choice B reason: Reports reduced nasal discharge is not an assessment information that indicates that the antitussive medication benzonatate is effective. Benzonatate is a medication that suppresses the cough reflex by numbing the throat and lungs. It does not affect the production or drainage of nasal secretions, which are caused by inflammation and infection in the upper respiratory tract.
Choice C reason: Able to sleep through the night is not an assessment information that indicates that the antitussive medication benzonatate is effective. Benzonatate is a medication that suppresses the cough reflex by numbing the throat and lungs. It does not have any sedative or hypnotic effects, which would promote sleep. However, by reducing coughing, benzonatate may indirectly improve the quality of sleep for the client.
Choice D reason: Denies having coughing spells is an assessment information that indicates that the antitussive medication benzonatate is effective. Benzonatate is a medication that suppresses the cough reflex by numbing the throat and lungs. It reduces the frequency and intensity of coughing, which can relieve discomfort and irritation for the client.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A reason: Sleeping soundly through the night is the desired outcome of administering zolpidem, which is a sedative-hypnotic that induces sleep by enhancing the activity of GABA, an inhibitory neurotransmitter. Zolpidem is used to treat insomnia, especially difficulty falling asleep.
Choice B reason: Decreasing episodes of incontinence is not a relevant outcome of administering zolpidem, which does not affect urinary function or bladder control. Incontinence may be caused by other factors, such as aging, prostate problems, or urinary tract infections.
Choice C reason: Improving ability to concentrate is not a pertinent outcome of administering zolpidem, which does not affect cognitive function or attention span. Zolpidem may actually impair memory and cause daytime drowsiness or confusion in some patients.
Choice D reason: Exhibiting fewer emotional outbursts is not a significant outcome of administering zolpidem, which does not affect mood or behavior. Zolpidem may actually cause paradoxical reactions, such as agitation, aggression, or hallucinations in some patients.
: [Zolpidem (Oral Route)]
: [Insomnia]
: [Urinary Incontinence]
: [Concentration Problems]
Correct Answer is ["167"]
Explanation
To find the answer, we can use the following formula:
(mL of fluid / hours of infusion) = mL/hr
Substituting the values from the question, we get:
(500 mL / 3 hours) = 166.67 mL/hr
Rounding to the nearest whole number, we get 167 mL/hr.
Therefore, the nurse should program the infusion pump to deliver 167 mL/hr of dextrose in 5% water IV.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
